In our study, even though institution 1 showed high sensitivity and specificity for p16, given the inconsistency between the institutions and the high amount of faint positive staining, p16 alone might not be as good as MTAP for determining CDKN2A/B status in meningiomas. This evidence concerns the gene CDKN2A and meningioma.